Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Pfizer
Approval Status: Approved October 1997
Treatment for: panic disorder/obsessive compulsive disorder

General Information

The U.S. Food and Drug Administration (FDA) approved Zoloft for the treatment of obsessive-compulsive disorder in children ages 6 to17 years of age. Zoloft has already been approved for treatment of panic disorder and obsessive-compulsive disorder in adults.